1. Lindenskov PH, Castellheim A, Saugstad OD, Mollnes TE. Meconium aspiration syndrome: possible pathophysiological mechanisms and future potential therapies. Neonatology. 2015; 107:225–30.
Article
2. Karabayir N, Demirel A, Bayramoglu E. Blood lactate level and meconium aspiration syndrome. Arch Gynecol Obstet. 2015; 291:849–53.
Article
3. Bhat RY, Rao A. Meconium-stained amniotic fluid and meconium aspiration syndrome: a prospective study. Ann Trop Paediatr. 2008; 28:199–203.
Article
4. Cleary GM, Wiswell TE. Meconium-stained amniotic fluid and the meconium aspiration syndrome. An update. Pediatr Clin North Am. 1998; 45:511–29.
5. Choi CW, Kim BI, Lee HJ, Joung KE, Shim GH, Lim IS, et al. Clinical characteristics of severe meconium aspiration syndrome. Korean J Pediatr. 2008; 51:713–21.
Article
6. Lee EC, Choi MG, Shim GH, Song YH, Chey MJ. Comorbid risk factors of persistent pulmonary hypertension of the newborn in infants with meconium aspiration syndrome. Neonatal Med. 2014; 21:166–71.
Article
7. Hsieh TK, Su BH, Chen AC, Lin TW, Tsai CH, Lin HC. Risk factors of meconium aspiration syndrome developing into persistent pulmonary hypertension of newborn. Acta Paediatr Taiwan. 2004; 45:203–7.
8. Ozkiraz S, Gokmen Z, Boke SB, Kilicdag H, Ozel D, Sert A. Lactate and lactate dehydrogenase in predicting the severity of transient tachypnea of the newborn. J Matern Fetal Neonatal Med. 2013; 26:1245–8.
Article
9. Lackmann GM. Influence of neonatal idiopathic respiratory distress syndrome on serum enzyme activities in premature healthy and asphyxiated newborns. Am J Perinatol. 1996; 13:329–34.
Article
10. An YS, Kim IU, Yang MY, Jeong HR, Kim HS. Serum enzymes in predicting transient tachypnea of newborn and respiratory distress syndrome. Korean J Perinatol. 2014; 25:284–91.
Article
11. Dargaville PA, Copnell B. The epidemiology of meconium aspiration syndrome: incidence, risk factors, therapies, and outcome. Pediatrics. 2006; 117:1712–21.
Article
12. Park MK, Pediatric cardiology for practitioners. 5th ed ed. St. Louis: Mosby;2008. p. p299–302.
13. Karlsson M, Wiberg-Itzel E, Chakkarapani E, Blennow M, Winbladh B, Thoresen M. Lactate dehydrogenase predicts hypoxic ischaemic encephalopathy in newborn infants: a preliminary study. Acta Paediatr. 2010; 99:1139–44.
Article
14. Liu WF, Harrington T. Delivery room risk factors for meconium aspiration syndrome. Am J Perinatol. 2002; 19:367–78.
Article
15. Lackmann GM, Töllner U, Mader R. Serum enzyme activities in fullterm asphyxiated and healthy newborns: enzyme kinetics during the first 144 hours of life. Enzyme Protein. 1993; 47:160–72.
Article
16. Karlsson M, Blennow M, Nemeth A, Winbladh B. Dynamics of hepatic enzyme activity following birth asphyxia. Acta Paediatr. 2006; 95:1405–11.
Article
17. Henrion J, Schapira M, Luwaert R, Colin L, Delannoy A, Heller FR. Hypoxic hepatitis: clinical and hemodynamic study in 142 consecutive cases. Medicine. 2003; 82:392–406.
18. Lackmann GM. Reference values for selected enzyme activities in serum from healthy human neonates. Clin Biochem. 1996; 29:599–602.
Article
19. Reddy S, Dutta S, Narang A. Evaluation of lactate dehydrogenase, creatine kinase and hepatic enzymes for the retrospective diagnosis of perinatal asphyxia among sick neonates. Indian Pediatr. 2008; 45:144–7.
20. Karlsson M, Dung KT, Thi TL, Borgström E, Jonstam K, Kasström L, et al. Lactate dehydrogenase as an indicator of severe illness in neonatal intensive care patients: a longitudinal cohort study. Acta Paediatr. 2012; 101:1225–31.
Article
21. Thureen PJ, Hall DM, Hoffenberg A, Tyson RW. Fatal meconium aspiration in spite of appropriate perinatal airway management: pulmonary and placental evidence of prenatal disease. Am J of Obstet Gynecol. 1997; 176:967–75.
Article